Victory Capital Management
ALT icon

Victory Capital Management’s Altimmune ALT Stock Holding History

Victory Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.5K Buy
21,218
+6,455
+44% +$19.3K ﹤0.01% 2371
2026
Q1 		$45.5K Buy
14,763
+2,833
+24% +$12K ﹤0.01% 2317
2025
Q4 		$43.1K Buy
11,930
+1,869
+19% +$8.15K ﹤0.01% 2342
2025
Q3 		$37.9K Buy
+10,061
New +$38.8K ﹤0.01% 2366
2020
Q2 		– Sell
-2,338
Closed -$8K – 2525
2020
Q1 		$8K Buy
+2,338
New +$5.38K ﹤0.01% 3137
2019
Q4 		– Sell
-2,325
Closed -$5K – 2649
2019
Q3 		$5K Buy
+2,325
New +$5.15K ﹤0.01% 3441

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's ALT Position: Q2 2026 in Review

Victory Capital Management increased its Altimmune (ALT) stake by 44% in Q2 2026, buying an estimated $19.3K and bringing the position to 21,218 shares worth $64.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Victory Capital Management first reported a position in ALT in Q3 2019 and has held it in 6 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Victory Capital Management held 21,218 shares of Altimmune worth $64.5K as of Q2 2026.
  • Victory Capital Management bought 6,455 Altimmune shares in Q2 2026, an estimated $19.3K.
  • Altimmune made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2371 holding.
  • Victory Capital Management first reported a position in Altimmune in Q3 2019 and has held it in 6 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.